Abstract
Purpose
To investigate the efficacy of our treatment of infantile hemangioma (IH)s retrospectively presenting as disfiguring or functionally threatening lesions.
Materials and methods
25 infants with IH treated with long-pulsed dye laser or laser with or without propranolol. Tumor fading after treatment was evaluated using both color and size rating scales, before, during and after treatment.
Results
6 infants were treated by laser, 11, oral propranolol and 8 using both treatments. Each treatment was effective for most IH with a median treatment duration of 7.7 months for laser, and 13.3 months for the latter two. Combination therapy was the most effective in both color-fading and size reduction by the 3rd month. Laser alone was most effective in color-fading with almost complete disappearance of most tumors. Oral propranolol to the three site-specific IHs was effective with disappearance of tumors. There were no apparent side effects related to laser treatment, but one infant suffered from allergy and another from bronchial asthma due to propranolol medication.
Conclusions
Most IHs discolored and regressed considerably with these treatments, including complete disappearance of the three functionally threatening lesions. This combined approach is quite useful for accelerating tumor regression.
Similar content being viewed by others
References
Keller RG, Patel KG (2015) Evidence-based medicine in the treatment of infantile hemangiomas. Fac Plast Surg Clin North Am 23:373–392. doi:10.1016/j.fsc.2015.04.009
Craiglow BG, Antaya RJ (2013) Management of infantile hemangiomas: current and potential pharmacotherapeutic approaches. Paediatr Drugs 15:133–138. doi:10.1007/s40272-013-0008-6
Vercellino N, Romanini MV, Pelegrini M, Rimini A, Occella C, Dalmonte P (2013) The use of propranolol for complicated infantile hemangiomas. Int J Dermatol 52:1140–1146. doi:10.1111/j.1365-4632.2012.05795
Batta K, Goodyear HM, Moss C, Williams HC, Hiller L, Waters R (2002) Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis. Lancet 360:521–527
Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358:2649–2651. doi:10.1056/NEJMc0708819
Kwon SH, Choi JW, Byun SY, Kim BR, Park KC, Youn SW, Huh CH, Na JI (2014) Effect of early long-pulse pulsed dye laser treatment in infantile hemangiomas. Dermatol Surg 40:405–411. doi:10.1111/dsu.12451
Enjolras O, Riche MC, Merland JJ, Escande JP (1990) Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 85:491–498
Storch CH, Hoeger PH (2010) Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 163:269–274. doi:10.1111/j.1365-2133.2010.09848.x
Drolet BA, Frommelt PC, Chamlin SL, Haggstrom A, Bauman NM, Chiu YE, Chun RH, Garzon MC, Holland KE, Liberman L, MacLellan-Tobert S, Mancini AJ, Metry D, Puttgen KB, Seefeldt M, Sidbury R, Ward KM, Blei F, Baselga E, Cassidy L, Darrow DH, Joachim S, Kwon EK, Martin K, Perkins J, Siegel DH, Boucek RJ, Frieden IJ (2013) Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 131:128–140. doi:10.1542/peds.2012-1691
Reddy KK, Blei F, Brauer JA, Waner M, Anolik R, Bernstein L, Brightman L, Hale E, Karen J, Weiss E, Geronemus RG (2013) Retrospective study of the treatment of infantile hemangiomas using a combination of propranolol and pulsed dye laser. Dermatol Surg 39:923–933. doi:10.1111/dsu.12158
Rodríguez-Ruiz M, Tellado MG, Del Pozo Losada J (2016) Combination of pulsed dye laser and propranolol in the treatment of ulcerated infantile haemangioma. An Pediatr. 84:92–96. doi:10.1016/j.anpedi.2015.04.007
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Furuta, S., Sato, H., Tsuji, S. et al. Effective treatment for infantile hemangioma with long-pulsed dye laser with oral propranolol medication: a preliminary report. Pediatr Surg Int 32, 857–862 (2016). https://doi.org/10.1007/s00383-016-3942-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00383-016-3942-x